지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2023.4
- 수록면
- 83 - 89 (7page)
- DOI
- 10.5045/br.2023.2023013
이용수
초록· 키워드
오류제보하기
Myeloproliferative neoplasms (MPNs) are clonal disorders of hematopoietic stem cells; these include polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). MPNs are inflammatory cancers, wherein the malignant clone generates cytokines that sustain the inflammatory drive in a self-perpetuating vicious cycle. The course of MPNs follows a biological continuum, that is, from early cancer stages (ET/PV) to advanced myelofibrosis as well as impending leukemic transformation. MPN-related symptoms, e.g., fatigue, general weakness, and itching, are caused by inflammatory cytokines. Thrombosis and bleeding are also exacerbated by inflammatory cytokines in patients with MPN. Until recently, the primary objective of ET and PV therapy was to increase survival rates by preventing thrombosis. However, several medications have recently demonstrated the ability to modify the course of the disease; symptom relief is expected for most patients. In addition, there is increasing interest in the active treatment of patients at low risk with PV and ET. This review focuses on the ET/PV treatment strategies as well as novel treatment options for clinical development.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Disease modifying agents of myeloproliferative neoplasms: a review
Blood Research
2021 .01
-
Disease modifying agents of myeloproliferative neoplasms: a review
Blood Research
2021 .04
-
Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Prognostication in myeloproliferative neoplasms, including mutational abnormalities
Blood Research
2023 .04
-
Myelofibrotic and leukemic transformation in 2016 WHO-defined Philadelphia-negative myeloproliferative neoplasm
Blood Research
2022 .03
-
침치료로 임상증상이 호전된 진성적혈구증가증 환자 치험 1례
대한한방내과학회지
2021 .10
-
청력 소실과 이명, 현훈을 동반한 진성 적혈구증가증 1예
임상이비인후과
2021 .09
-
골수증식 종양의 2017년 WHO 진단기준 주요 변경 사항의 이해
대한내과학회지
2018 .01
-
Pulmonary hypertension in patients with Philadelphia-negative myeloproliferative neoplasms: a single-center retrospective analysis of 225 patients
Blood Research
2020 .01
-
진성적혈구증가증/본태성혈소판증가증 치료의 발전
대한내과학회지
2016 .01
-
한방치료로 호전된 진성적혈구증가증으로 환자의 현훈 치험 1례
대한한방내과학회지
2020 .01
-
Clinical Implications of Quantitative JAK2 V617F Analysis using Droplet Digital PCR in Myeloproliferative Neoplasms
Annals of Laboratory Medicine
2018 .01
-
A case of histoplasmosis in a patient with MDS/MPN-U
Blood Research
2016 .01
-
GATA1 Expression in BCR/ABL1-negative Myeloproliferative Neoplasms
Annals of Laboratory Medicine
2018 .01
-
골수증식종양 진단의 발전
대한내과학회지
2016 .01
-
Gaze-Evoked and Perverted Head-Shaking Nystagmus in a Patient with Polycythemia Vera
Research in Vestibular Science
2017 .01
-
Calreticulin Exon 9 Mutations in Myeloproliferative Neoplasms
Annals of Laboratory Medicine
2015 .01
-
골수증식종양 환자에서 MPL W515 돌연변이 빈도와 임상혈액학적 특징
Laboratory Medicine Online
2015 .01
-
JAK2 V617F-Positive Acute Myeloid Leukemia: Clinicopathological Features of Two Cases
Laboratory Medicine Online
2022 .01
-
Myelodysplasia-Related Features of Acute Myeloid Leukemia Evolving From Philadelphia-Negative Myeloproliferative Neoplasms
Annals of Laboratory Medicine
2016 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0